FDA approves Taro Pharmaceutical Industries' levetiracetam tablets ANDA

Links shared publicly online about this topic.

1,409
total visits

FDA approves Taro Pharmaceutical Industries' levetiracetam tablets ANDA

Taro Pharmaceutical Industries Ltd. reported today that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 250 mg, 500 mg, 750 mg and 1000 mg (levetiracetam tablets).

View full resource at news-medical.net

Tags: Seizure, Seizure Medication, Epilepsy, Drug, Pharma, FDA, Keppra, Epilepsy Medication